Wave Life Sciences (WVE) Equity Ratio (2016 - 2025)
Wave Life Sciences' Equity Ratio history spans 11 years, with the latest figure at 0.81 for Q4 2025.
- For Q4 2025, Equity Ratio rose 36.47% year-over-year to 0.81; the TTM value through Dec 2025 reached 0.81, up 36.47%, while the annual FY2025 figure was 0.81, 36.47% up from the prior year.
- Equity Ratio reached 0.81 in Q4 2025 per WVE's latest filing, up from 0.52 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.81 in Q4 2025 to a low of 0.31 in Q4 2022.
- Average Equity Ratio over 5 years is 0.18, with a median of 0.14 recorded in 2022.
- Peak YoY movement for Equity Ratio: tumbled 40913.58% in 2023, then surged 3414.34% in 2025.
- A 5-year view of Equity Ratio shows it stood at 0.16 in 2021, then plummeted by 296.21% to 0.31 in 2022, then soared by 146.79% to 0.14 in 2023, then soared by 312.71% to 0.59 in 2024, then skyrocketed by 36.47% to 0.81 in 2025.
- Per Business Quant, the three most recent readings for WVE's Equity Ratio are 0.81 (Q4 2025), 0.52 (Q3 2025), and 0.55 (Q2 2025).